drugset / Trial / NCT00568061
Nitric Oxide in Myocardial Infarction Size
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to assess whether or not inhaled nitric oxide can decrease myocardial infarction (MI) size at 48-72 hours in patients presenting with an ST segment elevation MI (STEMI) who undergo successful percutaneous coronary intervention.
Timeline
- Start
- 2006-06
- Primary completion
- 2008-06
- Completion
- 2008-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Nitric Oxide | Other / unclassified | 80 ppm | Inhaled |